FindTrial
Sign In

Clinical study for olanzapine treating critically ill patients with delirium

Clinical study for olanzapine treating critically ill patients with delirium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032477
Enrollment
Unknown
Registered
2020-04-29
Start date
2016-01-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critically ill patients with delirium

Interventions

Group A:olanzapine
Group D:dexmedetomidine

Sponsors

Tongde Hopsital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged >=65 years old; 2. ciritical patients with delirium.

Exclusion criteria

Exclusion criteria: 1. those who experienced the medical history of severe head injury, stroke and other deseases in CNS; 2. those who experienced the medical history of mental disordes; 3. severe dysfunction with organs including liver and kidney; 4. with difficulities in communication; 5. sevre bradycardia; 6. addictive in alcohol and abuse of drugs.

Design outcomes

Primary

MeasureTime frame
days of mechanical ventilation;incidence of delirium;days of stay in ICU;—

Countries

China

Contacts

Public ContactJi Chunlian

Tongde Hopsital of Zhejiang Province

jicl0225@163.com+86 0571-89972333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026